Home-Based Tests for Cancer Patients
Point-of-care testing could offer a safer way to monitor cancer patients during a pandemic
Michael Schubert | | Quick Read
In the wake of COVID-19, many patients lack access to medical care – often because the risk of infection is too great for them to attend appointments. This is especially true of cancer patients, many of whom undergo treatment that compromises their immune systems. But these patients still need regular monitoring – so how can they receive that monitoring while being kept as safe as possible? Point-of-care testing (POCT) can help, and recent advances in the POCT sphere are making it an increasingly viable option. Niels Henrick Hollander, Leader of Changing Cancer Care in Zealand University Hospital’s Department of Clinical Oncology, shares his experience with POCT.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine